What is the desired effect of lidocaine and amiodarone in ventricular arrhythmias?

• A. Suppress ventricular automaticity
• B. Shorten the ventricular refractory period
• C. Stimulate automaticity in the atria
• D. Strengthen AV node conduction

Answer: (A)

In ventricular arrhythmias the goal is to quiet the abnormal ventricular pacemakers and interrupt circuits that can drive dangerous rhythms. Lidocaine and amiodarone acheive this by reducing automaticity in ventricular tissue and increasing the time the heart muscle is refractory to new impulses. By dampening ectopic ventricular activity and stabilizing the electrical environment, these drugs make it harder for a premature beat to trigger VT or VF.

Lidocaine does this mainly by blocking sodium channels in diseased ventricular tissue, which lowers excitability and suppresses ectopic pacemaker activity, especially in ischemic areas. Amiodarone adds a broad stabilizing effect: it prolongs repolarization and refractoriness across the ventricles, while also blunting automaticity and slowing conduction. The combination targets the underlying problem in ventricular arrhythmias—irregular ventricular automaticity—rather than altering atrial activity or AV conduction in a way that would worsen the rhythm. Shortening the ventricular refractory period or stimulating atrial automaticity would favor, not prevent, dangerous rhythms, so they are not the desired effects.